| Detected | Trial | Change |
|---|---|---|
| 2026-07-31 | NCT05675059 Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Pancreatic… |
Trial completed |
| 2026-07-31 | NCT07686250 Evaluation and Outcomes of SAVI Scout MD for Localized Breast Surgery |
Recruitment opened |
| 2026-07-31 | NCT04996823 Axitinib + Ipilimumab in Advanced Melanoma |
Enrollment closed, study ongoing |
| 2026-07-31 | NCT04335799 Reducing Weight and Elevated Stress Levels Using Educational and Behavioral Tools |
date change Primary completion moved earlier: 2026-04-14 -> 2025-12-19 |
| 2026-07-31 | NCT06963346 Study Investigating Intravesical HDAC Inhibition to Improve Response to Immuno-Oncology… |
Recruitment resumed after suspension |
| 2026-07-31 | NCT05438940 Support Through Remote Observation and Nutrition Guidance (STRONG) Program for… |
Trial completed |
| 2026-07-31 | NCT05438940 Support Through Remote Observation and Nutrition Guidance (STRONG) Program for… |
date change Completion moved earlier: 2026-06 -> 2025-06-12 |
| 2026-07-31 | NCT03628209 Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable Osteosarcoma |
date change Completion pushed: 2026-04 -> 2027-04 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-08-10 | NCT07754448 Libre Del Cigarrillo: Development of an mHealth Smoking Cessation App to Extend Reach of… | Not Yet Recruiting | |
| 2026-07-24 | NCT07725380 Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma | Phase 1/2 | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07357298 | Phase III Trial of Brain MRI Surveillance in Stage IV Breast Cancer | Breast Cancer | Recruiting |
| Phase 2/3 | |||
| NCT03495427 | PSMA-PET Imaging for Detecting Early Metastatic Prostate Cancer in Men w/ High Decipher… | Prostate Cancer | Recruiting |
| Phase 2 | |||
| NCT06597565 | A Phase II Study of ACR-368 and Low Dose Gemcitabine in R/M HNSCC | Head and Neck Squamous Cell Carcinoma | Recruiting |
| NCT06947083 | Elranatamab Post Cilta-cel in Patients With Clinical High Risk Relapsed Myeloma | Myeloma | Recruiting |
| NCT05301283 | Habitat Escalated Adaptive Therapy (HEAT), With Neoadjuvant Radiation for Soft Tissue… | High Grade Sarcoma | Recruiting |
| NCT05526989 | Study of the Combination Dostarlimab With Niraparib In Patients With Penile Carcinoma | Penile Carcinoma | Recruiting |
| NCT06121180 | Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma | Metastatic Uveal Melanoma | Recruiting |
| NCT06409390 | Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer | Metastatic Breast Cancer | Recruiting |
| NCT06350318 | Rituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas | Follicular Lymphoma | Recruiting |
| NCT05528133 | Genomically Guided Radiation Therapy in the Management of Triple Negative Breast Cancer | Triple Negative Breast Cancer | Recruiting |
| NCT06088498 | App for Reducing Cravings to Smoke | Smoking | Recruiting |
| NCT06511882 | Discontinuation of Hypomethylating Agent and Venetoclax in Patients With AML MRD | Acute Myeloid Leukemia | Recruiting |
| NCT05325632 | Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab &… | HER2-positive Breast Cancer | Recruiting |
| NCT05757219 | Itacitinib Pre-modulation in DLBCL Receiving CAR T Cell Therapy | Diffuse Large B Cell Lymphoma | Recruiting |
| NCT06104592 | Single-Arm Comprehensive Ablative Bridging Irradiation I Prior to CD19 CAR-T In High-Risk… | Large B-cell Lymphoma | Recruiting |
| NCT06144606 | Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic… | B-Cell Lymphoblastic Leukemia | Recruiting |
| NCT06553872 | Phase 2 Open Label Randomized Study of Pirtobrutinib and Brexucabtagene Autoleucel in R/R… | Mantle Cell Lymphoma | Recruiting |
| NCT07276386 | Phase 2 Combination of Melphalan/HDS Via PHP + Tebentafusp in Treating Metastatic Uveal… | Metastatic Uveal Melanoma | Recruiting |
| NCT04562129 | IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients | Melanoma Stage III | Recruiting |
| NCT06137274 | Phase 2 Trial of Adaptive Radiotherapy Boost for HNSCC | Squamous Cell Carcinoma | Recruiting |
| NCT06295159 | Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma | Melanoma Stage III | Recruiting |
| NCT06553885 | Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC | Metastatic Colorectal Cancer | Recruiting |
| NCT06660368 | BCL2i CLAG-M in R/R Acute Myeloid Leukemia | Relapsed or Refractory Acute Myeloid Leukemia (AML) | Recruiting |
| NCT07007273 | Pembrolizumab for Advanced Cutaneous Sarcomas Not Including Angiosarcoma | Cutaneous Sarcoma | Recruiting |
| NCT06760156 | Tafasitamab and Lenalidomide as First Salvage Therapy for Residual Large B Cell Lym | Large B-cell Lymphoma | Recruiting |